Premier Alternatives

Kalderos

Chicago, IL · Founded 2016 · Privately Held (backing)

Developer of medicine management platform designed to analyze the complex coordination of drug discount programs. Kalderos is based in Chicago, IL and was founded in 2016. Its last reported valuation was $170 million in Sep 2022. It has raised $108 million across 4 recorded rounds; the latest was a $26.4 million early-stage round in Dec 2024.

Last reported valuation
$170.0M
Oct 2026
Priced at
—
Total raised
$108.5M
Last round
Early Stage VC
Dec 2024

Kalderos key facts

as of Oct 2026
  • Developer of medicine management platform designed to analyze the complex coordination of drug discount programs.
  • Kalderos is valued at approximately $170.0M as of Oct 2026 (last reported valuation).
  • It has raised $108.5M across 4 recorded rounds; the latest was Early Stage VC ($26.4M) in Dec 2024.
  • Notable investors include Alumni Ventures, TriplePoint Capital, Bain Capital Ventures, New Leaf Venture, Savano Capital Partners — 7 tracked in total.
  • Kalderos has filed 4 Form Ds with the SEC since 2019, most recently Jan 2025 ($26.4M sold to 8 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$170.0M

Kalderos's last reported valuation, Sep 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Kalderos with a free account
  • ·Watch Kalderos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kalderos funding rounds

4 rounds
Dec 2024Early Stage VC$26.4MSEC filing▮
Aug 2022Early Stage VC$14.9MSEC filing▮
May 2020Early Stage VC$28.0MSEC filing▮
Apr 2019Early Stage VC$7.0MSEC filing▮
Full funding history →

Kalderos valuation

Kalderos's last reported valuation was $170 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Kalderos raised?

Kalderos has raised $108 million across 4 recorded rounds since 2019. The largest was a $7 million early-stage round in Apr 2019; the most recent was a $26.4 million early-stage round in Dec 2024.

Kalderos has filed 4 Form Ds with the SEC since 2019, most recently in Jan 2025 ($26.4 million sold to 8 investors).

Kalderos investors

7 investors are on record for Kalderos, including Alumni Ventures, TriplePoint Capital, Bain Capital Ventures and New Leaf Venture. By type, the record holds 5 venture capital firms and 1 private equity firm. The early-stage round in Dec 2024 drew 8 investors.

About Kalderos

Developer of medicine management platform designed to analyze the complex coordination of drug discount programs. The company's platform offers data management, provides clear and customizable views into the data available in the cloud with immediate access to targeted insights and offers claims verification, dispute resolution and discount monitoring, enabling clients to get a streamlined process for communicating, verifying and payment.

Sector
Information Technology
HQ
Chicago, IL, United States
Founded
2016
Employees
127
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.